Faith Regional Health Services Hospice 1500 Koenigstein, Norfolk, NE, 68701 | |
(402) 644-7453 |
News Archive
Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo, according to a new article in the Archives of Internal Medicine, one of the JAMA/Archives journals.
The period after hospital discharge is a high-risk time for people who use illicit opioids such as heroin, according to new research publishing October 5th in the open access journal PLOS Medicine.
Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
Unravelling the mechanisms of cardiac fibrosis will lead to the discovery of therapeutic target candidates for various cardiac diseases. FIBRO-TARGETS brings together eleven European expert teams from six different countries both from public research institutes and European biotechs.
› Verified 1 days ago
Name | Faith Regional Health Services Hospice |
---|---|
Location | 1500 Koenigstein, Norfolk, Nebraska |
Hospice ID | 281509 |
Category | Part of a Home Health Agency |
Ownership Type | Voluntary Non-profit - Private |
Profit Type | NON-PROFIT |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 590 |
News Archive
Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo, according to a new article in the Archives of Internal Medicine, one of the JAMA/Archives journals.
The period after hospital discharge is a high-risk time for people who use illicit opioids such as heroin, according to new research publishing October 5th in the open access journal PLOS Medicine.
Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
Unravelling the mechanisms of cardiac fibrosis will lead to the discovery of therapeutic target candidates for various cardiac diseases. FIBRO-TARGETS brings together eleven European expert teams from six different countries both from public research institutes and European biotechs.
› Verified 1 days ago
NPI Number | 1265536395 |
Organization Name | Faith Regional Health Services |
Address | 1500 Koenigstein Ave Norfolk, Nebraska, 68701 |
Phone Number | (402)644-7453 |
News Archive
Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo, according to a new article in the Archives of Internal Medicine, one of the JAMA/Archives journals.
The period after hospital discharge is a high-risk time for people who use illicit opioids such as heroin, according to new research publishing October 5th in the open access journal PLOS Medicine.
Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
Unravelling the mechanisms of cardiac fibrosis will lead to the discovery of therapeutic target candidates for various cardiac diseases. FIBRO-TARGETS brings together eleven European expert teams from six different countries both from public research institutes and European biotechs.
› Verified 1 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 98.4 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo, according to a new article in the Archives of Internal Medicine, one of the JAMA/Archives journals.
The period after hospital discharge is a high-risk time for people who use illicit opioids such as heroin, according to new research publishing October 5th in the open access journal PLOS Medicine.
Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
Unravelling the mechanisms of cardiac fibrosis will lead to the discovery of therapeutic target candidates for various cardiac diseases. FIBRO-TARGETS brings together eleven European expert teams from six different countries both from public research institutes and European biotechs.
› Verified 1 days ago
Home Health Aides | 2 |
Counselors | 0.4 |
Medical Social Workers | 0.8 |
Registered Nurses | 4.2 |
Other Personnel | 1 |
Total Employees | 8.4 |
---|
News Archive
Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo, according to a new article in the Archives of Internal Medicine, one of the JAMA/Archives journals.
The period after hospital discharge is a high-risk time for people who use illicit opioids such as heroin, according to new research publishing October 5th in the open access journal PLOS Medicine.
Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
Unravelling the mechanisms of cardiac fibrosis will lead to the discovery of therapeutic target candidates for various cardiac diseases. FIBRO-TARGETS brings together eleven European expert teams from six different countries both from public research institutes and European biotechs.
› Verified 1 days ago
Others | 0.5 |
Total Volunteers | 0.5 |
---|
News Archive
Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo, according to a new article in the Archives of Internal Medicine, one of the JAMA/Archives journals.
The period after hospital discharge is a high-risk time for people who use illicit opioids such as heroin, according to new research publishing October 5th in the open access journal PLOS Medicine.
Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
Unravelling the mechanisms of cardiac fibrosis will lead to the discovery of therapeutic target candidates for various cardiac diseases. FIBRO-TARGETS brings together eleven European expert teams from six different countries both from public research institutes and European biotechs.
› Verified 1 days ago
Faith Regional Health Services Hospice Location: 1500 Koenigstein, Norfolk, Nebraska, 68701 Phone: (402) 644-7453 |
Aseracare Hospice Location: 120 N 27th Street, Ste. 300, Norfolk, Nebraska, 68701 Phone: (402) 644-7453 |